Company
Reunion Neuroscience
Advancing next generation 5HT2A serotonergic medicines for large, high-need, neuropsychiatry populations.
Also known as Reunion Neuroscience Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Morristown, New Jersey, United States
- Legal name
- Reunion Neuroscience Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Reunion is a clinical-stage biopharmaceutical company developing innovative therapeutics for underserved mental health disorders.
Funding snapshot
- Total raised
- $133MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $133M2025-09-16
Funding rounds
- Series A
- $133M2025-09-16, Company stated
- Round, 2024
- $120M2024-01-12, SEC form D sold, 9 investors
Products
- Other
- luvesilocin
Loading relationship preview